Iradimed Corporation2024财年实现净利润19.23百万美元，同比增加11.87%

市场透视2025-02-17

2月17日，Iradimed Corporation（IRMD.US）公布财报，公告显示公司2024财年净利润为19.23百万美元，同比增加11.87%；其中营业收入为73.24百万美元，同比增加11.71%，每股基本收益为1.52美元。从资产负债表来看，Iradimed Corporation（IRMD.US）总负债11.51百万美元，其中短期债务--，资产负债比为8.55，流动比率为8.78。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2512953704?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-17 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2512953704","market":"us","top_or_hot":-1,"title":"Iradimed Corporation2024财年实现净利润19.23百万美元，同比增加11.87%","media":"市场透视","content":"<div>\n<p>2月17日，Iradimed Corporation（IRMD.US）公布财报，公告显示公司2024财年净利润为19.23百万美元，同比增加11.87%；其中营业收入为73.24百万美元，同比增加11.71%，每股基本收益为1.52美元。从资产负债表来看，Iradimed Corporation（IRMD.US）总负债11.51百万美元，其中短期债务--，资产负债比为8.55，流动比率为8.78。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000149a2481c45&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iradimed Corporation2024财年实现净利润19.23百万美元，同比增加11.87%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIradimed Corporation2024财年实现净利润19.23百万美元，同比增加11.87%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-17 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000149a2481c45&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月17日，Iradimed Corporation（IRMD.US）公布财报，公告显示公司2024财年净利润为19.23百万美元，同比增加11.87%；其中营业收入为73.24百万美元，同比增加11.71%，每股基本收益为1.52美元。从资产负债表来看，Iradimed Corporation（IRMD.US）总负债11.51百万美元，其中短期债务--，资产负债比为8.55，流动比率为8.78。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000149a2481c45&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRMD","symbol_name":"iRadimed Corporation","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000149a2481c45&s=b","article_id":"2512953704","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000149a2481c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2512953704","pubTimestamp":1739721679,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2月17日，Iradimed Corporation公布财报，公告显示公司2024财年净利润为19.23百万美元，同比增加11.87%；其中营业收入为73.24百万美元，同比增加11.71%，每股基本收益为1.52美元。从资产负债表来看，Iradimed Corporation总负债11.51百万美元，其中短期债务--，资产负债比为8.55，流动比率为8.78。机构评级：截至2025年2月17日，当前有2家机构对Iradimed Corporation目标价做出预测，其中目标均价为71.00美元，其中最低目标价为70.00美元，最高目标价为72.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"IRMD":"iRadimed Corporation"},"translate_title":"Iradimed Corporation achieved net profit of US $19.23 million in fiscal year 2024, a year-on-year increase of 11.87%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRMD":0.9},"content_text":"2月17日，Iradimed Corporation（IRMD.US）公布财报，公告显示公司2024财年净利润为19.23百万美元，同比增加11.87%；其中营业收入为73.24百万美元，同比增加11.71%，每股基本收益为1.52美元。从资产负债表来看，Iradimed Corporation（IRMD.US）总负债11.51百万美元，其中短期债务--，资产负债比为8.55，流动比率为8.78。机构评级：截至2025年2月17日，当前有2家机构对Iradimed Corporation目标价做出预测，其中目标均价为71.00美元，其中最低目标价为70.00美元，最高目标价为72.00美元。公司简介：iRadimed Corp 开发、制造、营销和分销磁共振成像 (MRI) 兼容静脉 (IV) 输液泵系统、磁共振成像兼容的患者生命体征监测系统以及与之相关的配件和服务。 该公司提供非磁性静脉输液泵系统，旨在在磁共振成像手术期间安全使用。 该公司的磁共振成像产品销往美国和国际上的医院和急症护理机构。 它的大部分收入来自美国。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2512953704","isCrawlerRequest":true}